Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–78.

Article  PubMed  Google Scholar 

Du L, Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am. 2020;49(4):643–54.

Article  PubMed  Google Scholar 

Bromke MA, Neubauer K, Kempiński R, Krzystek-Korpacka M. Faecal Calprotectin in Assessment of Mucosal Healing in adults with inflammatory bowel disease: a Meta-analysis. J Clin Med. 2021;10(10).

Lopetuso LR, Petito V, Zambrano D, Orlando D, Dal Lago A, Serrichhio L, et al. Gut microbiota: a Key Modulator of Intestinal Healing in Inflammatory Bowel Disease. Dig Dis. 2016;34(3):202–9.

Article  CAS  PubMed  Google Scholar 

Crispin A, Birkner B, Munte A, Nusko G, Mansmann U. Process quality and incidence of acute complications in a series of more than 230,000 outpatient colonoscopies. Endoscopy. 2009;41(12):1018–25.

Article  CAS  PubMed  Google Scholar 

Boal Carvalho P, Cotter J. Mucosal Healing in Ulcerative Colitis: a Comprehensive Review. Drugs. 2017;77(2):159–73.

Article  CAS  PubMed  Google Scholar 

Vidal-Lletjós S, Beaumont M, Tomé D, Benamouzig R, Blachier F, Lan A. Dietary protein and amino acid supplementation in inflammatory bowel disease course: what impact on the Colonic Mucosa? Nutrients. 2017;9(3):310.

Zheng X, Zhu Y, Zhao Z, Chu Y, Yang W. The role of amino acid metabolism in inflammatory bowel disease and other inflammatory diseases. Front Immunol. 2023;14:1284133.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, Panaccione R, et al. Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res. 2012;11(6):3344–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patti GJ, Yanes O, Siuzdak G, Innovation. Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012;13(4):263–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCann JR, Rawls JF. Essential amino acid metabolites as chemical mediators of host-microbe interaction in the gut. Annu Rev Microbiol. 2023;15(77):479-497.

Sokol H, Seksik P. The intestinal microbiota in inflammatory bowel diseases: time to connect with the host. Curr Opin Gastroenterol. 2010;26(4):327–31.

Article  PubMed  Google Scholar 

Lee M, Chang EB. Inflammatory Bowel diseases (IBD) and the Microbiome-searching the crime scene for clues. Gastroenterology. 2021;160(2):524–37.

Article  CAS  PubMed  Google Scholar 

Pull SL, Doherty JM, Mills JC, Gordon JI, Stappenbeck TS. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci U S A. 2005;102(1):99–104.

Article  CAS  PubMed  Google Scholar 

Filidou E, Kolios G. Probiotics in intestinal mucosal healing: a new therapy or an old friend? Pharmaceuticals (Basel). 2021;14(11):1181.

Knight R, Vrbanac A, Taylor BC, Aksenov A, Callewaert C, Debelius J, et al. Best practices for analysing microbiomes. Nat Rev Microbiol. 2018;16(7):410–22.

Article  CAS  PubMed  Google Scholar 

Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, et al. Third European evidence-based Consensus on diagnosis and management of Ulcerative Colitis. Part 1: definitions, Diagnosis, extra-intestinal manifestations, pregnancy, Cancer Surveillance, surgery, and Ileo-anal Pouch disorders. J Crohns Colitis. 2017;11(6):649–70.

Article  PubMed  Google Scholar 

Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317(26):1625–9.

Article  CAS  PubMed  Google Scholar 

Buchfink B, Xie C, Huson DH. Fast and sensitive protein alignment using DIAMOND. Nat Methods. 2015;12(1):59–60.

Article  CAS  PubMed  Google Scholar 

Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103.

Article  CAS  PubMed  Google Scholar 

Karlsson FH, Fåk F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun. 2012;3:1245.

Article  PubMed  Google Scholar 

Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun. 2015;6:6528.

Article  CAS  PubMed  Google Scholar 

White JR, Nagarajan N, Pop M. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol. 2009;5(4):e1000352.

Article  PubMed  PubMed Central  Google Scholar 

Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.

Article  PubMed  PubMed Central  Google Scholar 

Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353–61.

Article  CAS  PubMed  Google Scholar 

Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105(43):16731–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sartor RB, Wu GD. Roles for intestinal Bacteria, viruses, and Fungi in Pathogenesis of Inflammatory Bowel diseases and therapeutic approaches. Gastroenterology. 2017;152(2):327–e394.

Article  CAS  PubMed  Google Scholar 

Chu H, Khosravi A, Kusumawardhani IP, Kwon AH, Vasconcelos AC, Cunha LD, et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science. 2016;352(6289):1116–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan TJ, Goeser L, Lu K, Faith JJ, Hansen JJ. Enterococcus faecalis glucosamine metabolism exacerbates experimental colitis. Cell Mol Gastroenterol Hepatol. 2021;12(4):1373–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balish E, Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol. 2002;160(6):2253–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14(3):141–53.

Article  CAS  PubMed  Google Scholar 

Bosch S, El Hassani ME, Brizzio Brentar S, Ayada M, Bakkali I, Jansen A. Fecal amino acid profiles exceed accuracy of serum amino acids in diagnosing Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2020;71(3):371–5.

Article  CAS  PubMed  Google Scholar 

Lins Neto MÁF, Verdi GMX, Veras AO, Veras MO, Caetano LC, Ursulino JS, USE OF METABOLOMICS TO THE DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE. Arq Gastroenterol. 2020;57(3):311–5.

Article  PubMed  Google Scholar 

Balasubramanian K, Kumar S, Singh RR, Sharma U, Ahuja V, Makharia GK, et al. Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. Magn Reson Imaging. 2009;27(1):79–86.

Article